KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silicon Laboratories (SLAB) Common Equity (2016 - 2025)

Historic Common Equity for Silicon Laboratories (SLAB) over the last 17 years, with Q4 2025 value amounting to $1.1 billion.

  • Silicon Laboratories' Common Equity fell 98.7% to $1.1 billion in Q4 2025 from the same period last year, while for Oct 2025 it was $1.1 billion, marking a year-over-year decrease of 98.7%. This contributed to the annual value of $1.1 billion for FY2024, which is 1064.47% down from last year.
  • As of Q4 2025, Silicon Laboratories' Common Equity stood at $1.1 billion, which was down 98.7% from $1.1 billion recorded in Q3 2025.
  • Silicon Laboratories' Common Equity's 5-year high stood at $2.6 billion during Q4 2021, with a 5-year trough of $1.1 billion in Q3 2025.
  • Moreover, its 5-year median value for Common Equity was $1.2 billion (2021), whereas its average is $1.4 billion.
  • As far as peak fluctuations go, Silicon Laboratories' Common Equity soared by 12627.93% in 2021, and later tumbled by 4139.39% in 2022.
  • Over the past 5 years, Silicon Laboratories' Common Equity (Quarter) stood at $2.6 billion in 2021, then tumbled by 46.93% to $1.4 billion in 2022, then dropped by 13.97% to $1.2 billion in 2023, then fell by 10.64% to $1.1 billion in 2024, then fell by 0.86% to $1.1 billion in 2025.
  • Its last three reported values are $1.1 billion in Q4 2025, $1.1 billion for Q3 2025, and $1.1 billion during Q2 2025.